127 related articles for article (PubMed ID: 2121297)
41. c-myb but not c-myc suppresses the hemin-induced nonterminal expression of hemoglobin by murine erythroleukemia cells.
Prochownik EV
Blood; 1989 Feb; 73(3):782-6. PubMed ID: 2644989
[TBL] [Abstract][Full Text] [Related]
42. Different members of the jun proto-oncogene family exhibit distinct patterns of expression in response to type beta transforming growth factor.
Li L; Hu JS; Olson EN
J Biol Chem; 1990 Jan; 265(3):1556-62. PubMed ID: 2104845
[TBL] [Abstract][Full Text] [Related]
43. Regulation of c-fos, c-jun, jun-B, and c-myc messenger ribonucleic acids by gonadotropin and growth factors in cultured pig Leydig cell.
Hall SH; Berthelon MC; Avallet O; Saez JM
Endocrinology; 1991 Sep; 129(3):1243-9. PubMed ID: 1651842
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells.
Mechti N; Piechaczyk M; Blanchard JM; Marty L; Bonnieu A; Jeanteur P; Lebleu B
Nucleic Acids Res; 1986 Dec; 14(24):9653-66. PubMed ID: 3468485
[TBL] [Abstract][Full Text] [Related]
45. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
Chen ZX
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
[TBL] [Abstract][Full Text] [Related]
46. Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells.
Alitalo R; Partanen J; Pertovaara L; Hölttä E; Sistonen L; Andersson L; Alitalo K
Blood; 1990 May; 75(10):1974-82. PubMed ID: 2159816
[TBL] [Abstract][Full Text] [Related]
47. Cellular-oncogene expression in Friend erythroleukemia cells: relationship to differentiation, commitment and TPA effects.
Giroldi L; Hollstein M; Yamasaki H
Carcinogenesis; 1988 May; 9(5):817-21. PubMed ID: 3163274
[TBL] [Abstract][Full Text] [Related]
48. p45(NFE2) is a negative regulator of erythroid proliferation which contributes to the progression of Friend virus-induced erythroleukemias.
Li YJ; Higgins RR; Pak BJ; Shivdasani RA; Ney PA; Archer M; Ben-David Y
Mol Cell Biol; 2001 Jan; 21(1):73-80. PubMed ID: 11113182
[TBL] [Abstract][Full Text] [Related]
49. The induction of Friend erythroleukaemia differentiation is markedly affected by expression of a transfected c-myb cDNA.
McMahon J; Howe KM; Watson RJ
Oncogene; 1988 Dec; 3(6):717-20. PubMed ID: 2577875
[TBL] [Abstract][Full Text] [Related]
50. Divergent patterns of immediate early gene expression in response to thyroid-stimulating hormone and insulin-like growth factor I in Wistar rat thyrocytes.
Tominaga T; Dela Cruz J; Burrow GN; Meinkoth JL
Endocrinology; 1994 Sep; 135(3):1212-9. PubMed ID: 8070365
[TBL] [Abstract][Full Text] [Related]
51. Acetylcholinesterase in murine erythroleukemia (Friend) cells: evidence for megakaryocyte-like expression and potential growth-regulatory role of enzyme activity.
Paoletti F; Mocali A; Vannucchi AM
Blood; 1992 Jun; 79(11):2873-9. PubMed ID: 1586735
[TBL] [Abstract][Full Text] [Related]
52. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation.
Suhasini M; Reddy CD; Reddy EP; DiDonato JA; Pilz RB
Oncogene; 1997 Oct; 15(15):1859-70. PubMed ID: 9362453
[TBL] [Abstract][Full Text] [Related]
53. Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation.
Pertovaara L; Sistonen L; Bos TJ; Vogt PK; Keski-Oja J; Alitalo K
Mol Cell Biol; 1989 Mar; 9(3):1255-62. PubMed ID: 2725496
[TBL] [Abstract][Full Text] [Related]
54. Transformation-specific pattern of phosphorylation of c-Jun, Jun-B, Jun-D and Egr-1 in v-sis transformed cells.
Grover-Bardwick A; Adamson E; Mercola D
Carcinogenesis; 1994 Aug; 15(8):1667-74. PubMed ID: 8055649
[TBL] [Abstract][Full Text] [Related]
55. The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element.
Nicolaides NC; Correa I; Casadevall C; Travali S; Soprano KJ; Calabretta B
J Biol Chem; 1992 Sep; 267(27):19665-72. PubMed ID: 1527086
[TBL] [Abstract][Full Text] [Related]
56. Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiation.
Coutts M; Cui K; Davis KL; Keutzer JC; Sytkowski AJ
Blood; 1999 May; 93(10):3369-78. PubMed ID: 10233889
[TBL] [Abstract][Full Text] [Related]
57. c-myc protooncogene expression in mouse erythroleukemia cells.
Lachman HM
Environ Health Perspect; 1989 Mar; 80():161-72. PubMed ID: 2647476
[TBL] [Abstract][Full Text] [Related]
58. Transient inhibition of initiation of S-phase associated with dimethyl sulfoxide induction of murine erythroleukemia cells to erythroid differentiation.
Terada M; Fried J; Nudel U; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):248-52. PubMed ID: 64982
[TBL] [Abstract][Full Text] [Related]
59. Induced erythroleukemia differentiation: cellular and molecular aspects.
Rifkind RA; Sheffery M; Marks PA
Blood Cells; 1987; 13(1-2):277-84. PubMed ID: 3311222
[TBL] [Abstract][Full Text] [Related]
60. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
